Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Predictive Technology Group Inc (PRED)

Predictive Technology Group Inc (PRED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Predictive Technology Group Inc 2735 PARLEYS WAY SUITE 205 SALT LAKE CITY UT 84109 USA

www.predictivetechnologygroup.com P: 888-407-9761

Description:

Predictive Technology Group, Inc. is a therapeutics and life sciences company, in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The company through its' wholly-owned subsidiaries Predictive Therapeutics and Predictive Biotech focuses on clinical categories consists of Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Biotech efforts to advance regenerative medicine and Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. Predictive Technology Group, Inc. is based in Salt Lake City, UT.

Key Statistics

Overview:

Market Capitalization, $K 158
Enterprise Value, $K 4,298
Shares Outstanding, K 316,672
Annual Sales, $ 24,440 K
Annual Net Income, $ -85,770 K
Last Quarter Sales, $ 6,890 K
Last Quarter Net Income, $ -7,390 K
EBIT, $ -1,460 K
EBITDA, $ 9,340 K
60-Month Beta -0.82
% of Institutional Shareholders 0.00%
Float, K 316,672
% Float 100.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 66.67%
3-Year Return -99.69%
5-Year Return -99.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 07/04/22
Earnings Per Share ttm -0.02
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PRED Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -350.94%
Debt/Equity 0.09
Price/Sales 0.02
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.11
Interest Coverage -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar